91 related articles for article (PubMed ID: 18645736)
1. The effect of donepezil on increased regional cerebral blood flow in the posterior cingulate cortex of a patient with Parkinson's disease dementia.
Imamura K; Wada-Isoe K; Kowa H; Tanabe Y; Nakashima K
Neurocase; 2008; 14(3):271-5. PubMed ID: 18645736
[TBL] [Abstract][Full Text] [Related]
2. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
Iizuka T; Kameyama M
Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
[TBL] [Abstract][Full Text] [Related]
5. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
Shimizu S; Hanyu H; Iwamoto T; Koizumi K; Abe K
J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
[TBL] [Abstract][Full Text] [Related]
6. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
Tanaka M; Namiki C; Thuy DH; Yoshida H; Kawasaki K; Hashikawa K; Fukuyama H; Kita T
J Neurol Sci; 2004 Oct; 225(1-2):135-41. PubMed ID: 15465097
[TBL] [Abstract][Full Text] [Related]
7. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
[TBL] [Abstract][Full Text] [Related]
8. The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury.
Kim YW; Kim DY; Shin JC; Park CI; Lee JD
Clin Neuropharmacol; 2009; 32(2):63-8. PubMed ID: 18978490
[TBL] [Abstract][Full Text] [Related]
9. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N
Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT.
Niwa H; Koumoto C; Shiga T; Takeuchi J; Mishima S; Segawa T; Atsumi T; Shimizu C; Koike T; Yoshioka N
Diabetes Res Clin Pract; 2006 May; 72(2):142-7. PubMed ID: 16325958
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia.
Hiraoka K; Okamura N; Funaki Y; Hayashi A; Tashiro M; Hisanaga K; Fujii T; Takeda A; Yanai K; Iwata R; Mori E
Eur Neurol; 2012; 68(3):137-43. PubMed ID: 22832236
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic and perfusion brain networks in Parkinson disease dementia.
Colloby SJ; McKeith IG; Burn DJ; Wyper DJ; O'Brien JT; Taylor JP
Neurology; 2016 Jul; 87(2):178-85. PubMed ID: 27306636
[TBL] [Abstract][Full Text] [Related]
13. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
Hashimoto M; Yatabe Y; Kaneda K; Honda K; Ikeda M
Psychogeriatrics; 2009 Dec; 9(4):196-203. PubMed ID: 20377821
[TBL] [Abstract][Full Text] [Related]
14. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
Nakano S; Asada T; Matsuda H; Uno M; Takasaki M
J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
[TBL] [Abstract][Full Text] [Related]
15. Responses to donepezil in Alzheimer's disease and Parkinson's disease.
Mori S
Ann N Y Acad Sci; 2002 Nov; 977():493-500. PubMed ID: 12480791
[TBL] [Abstract][Full Text] [Related]
16. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
Aarsland D; Hutchinson M; Larsen JP
Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
[TBL] [Abstract][Full Text] [Related]
17. Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB.
Mori T; Ikeda M; Fukuhara R; Nestor PJ; Tanabe H
Neurology; 2006 Mar; 66(6):935-7. PubMed ID: 16567718
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT].
Sakai T; Kuzuhara S
No To Shinkei; 2006 Jan; 58(1):29-37. PubMed ID: 16482919
[TBL] [Abstract][Full Text] [Related]
19. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of donepezil on cerebral blood flow velocity in Alzheimer's disease.
Ghorbani A; Chitsaz A; Shishegar M; Akbari M
Neurosciences (Riyadh); 2010 Jul; 15(3):172-6. PubMed ID: 20831025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
